{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\n", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 23, "end": 37, "label": "DRUG_TYPE", "text": "antiretroviral"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 102, "end": 105, "label": "PATHOGEN", "text": "HIV"}, {"start": 152, "end": 155, "label": "DRUG_TYPE", "text": "ART"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 231, "processing_time": "2025-12-17T23:31:59.041200", "hash": "5aea62fd7489f5cd4a817613d778e4ba"}, "stats": {"rule_based_entities": 6, "llm_entities": 0, "total_entities": 6, "rule_stats": {"REVIEW_TYPE": 1, "N_STUDIES": 1, "PATHOGEN": 1, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 21, "end": 23, "label": "PATHOGEN", "text": "TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-17T23:31:59.041987", "hash": "b704ab89ed52a283729490c1cb2714ef"}, "stats": {"rule_based_entities": 8, "llm_entities": 0, "total_entities": 8, "rule_stats": {"REVIEW_TYPE": 2, "N_STUDIES": 2, "PATHOGEN": 4, "CI": 1, "DRUG_TYPE": 2, "COUNTRY": 3}}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-17T23:31:59.042789", "hash": "e06836707d0ee7ee126060ed987d2bc8"}, "stats": {"rule_based_entities": 4, "llm_entities": 0, "total_entities": 4, "rule_stats": {"REVIEW_TYPE": 3, "N_STUDIES": 2, "PATHOGEN": 5, "CI": 2, "DRUG_TYPE": 2, "COUNTRY": 3, "DISEASE": 1, "EFFECT_MEASURE": 1}}}
{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\nWe did a database search on the 10th of Dec 2025", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 23, "end": 37, "label": "DRUG_TYPE", "text": "antiretroviral"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 102, "end": 105, "label": "PATHOGEN", "text": "HIV"}, {"start": 152, "end": 155, "label": "DRUG_TYPE", "text": "ART"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 279, "processing_time": "2025-12-17T23:33:13.847841", "hash": "31e53c81ccdc3038f35bb736a551451f"}, "stats": {"rule_based_entities": 6, "llm_entities": 0, "total_entities": 6, "rule_stats": {"REVIEW_TYPE": 1, "N_STUDIES": 1, "PATHOGEN": 1, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 21, "end": 23, "label": "PATHOGEN", "text": "TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-17T23:33:13.848927", "hash": "b704ab89ed52a283729490c1cb2714ef"}, "stats": {"rule_based_entities": 8, "llm_entities": 0, "total_entities": 8, "rule_stats": {"REVIEW_TYPE": 2, "N_STUDIES": 2, "PATHOGEN": 4, "CI": 1, "DRUG_TYPE": 2, "COUNTRY": 3}}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-17T23:33:13.849358", "hash": "e06836707d0ee7ee126060ed987d2bc8"}, "stats": {"rule_based_entities": 4, "llm_entities": 0, "total_entities": 4, "rule_stats": {"REVIEW_TYPE": 3, "N_STUDIES": 2, "PATHOGEN": 5, "CI": 2, "DRUG_TYPE": 2, "COUNTRY": 3, "DISEASE": 1, "EFFECT_MEASURE": 1}}}
{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\nMethods:\nWe searched PubMed, Scopus, and Web of Science from January 1990 to March 2024. \nAfter removing duplicates, 1,240 records were screened, and 137 full-text articles were assessed for eligibility.\nSeventy articles were excluded due to incomplete data, leaving 67 studies for analysis. \nTwo reviewers independently screened all titles and abstracts.\n\nResults:\nA total of 67 studies (n = 88,345 participants) from 25 countries were included. \nThe largest sample sizes were from China (n = 35,812), the United States (n = 10,437), and Germany (n = 7,670). \nOther notable sample sizes included Bangladesh (n = 2,909), Ethiopia (n = 2,033), Egypt (n = 3,204), and Vietnam (n = 2,945).\nFourteen were randomized controlled trials, ten cohort studies, and three case-control studies.\n", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 23, "end": 37, "label": "DRUG_TYPE", "text": "antiretroviral"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 102, "end": 105, "label": "PATHOGEN", "text": "HIV"}, {"start": 152, "end": 155, "label": "DRUG_TYPE", "text": "ART"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}, {"start": 498, "end": 508, "label": "N_STUDIES", "text": "67 studies"}, {"start": 608, "end": 618, "label": "N_STUDIES", "text": "67 studies"}, {"start": 620, "end": 630, "label": "SAMPLE_SIZE", "text": "n = 88,345"}, {"start": 714, "end": 719, "label": "COUNTRY", "text": "China"}, {"start": 721, "end": 731, "label": "SAMPLE_SIZE", "text": "n = 35,812"}, {"start": 738, "end": 751, "label": "COUNTRY", "text": "United States"}, {"start": 753, "end": 763, "label": "SAMPLE_SIZE", "text": "n = 10,437"}, {"start": 779, "end": 788, "label": "SAMPLE_SIZE", "text": "n = 7,670"}, {"start": 840, "end": 849, "label": "SAMPLE_SIZE", "text": "n = 2,909"}, {"start": 862, "end": 871, "label": "SAMPLE_SIZE", "text": "n = 2,033"}, {"start": 881, "end": 890, "label": "SAMPLE_SIZE", "text": "n = 3,204"}, {"start": 906, "end": 915, "label": "SAMPLE_SIZE", "text": "n = 2,945"}, {"start": 992, "end": 1004, "label": "STUDY_DESIGN", "text": "case-control"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 1014, "processing_time": "2025-12-17T23:35:39.401760", "hash": "15c82ac190e922a6da5864c93d3736d2"}, "stats": {"rule_based_entities": 19, "llm_entities": 0, "total_entities": 19, "rule_stats": {"REVIEW_TYPE": 1, "STUDY_DESIGN": 1, "N_STUDIES": 3, "PATHOGEN": 1, "COUNTRY": 2, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 21, "end": 23, "label": "PATHOGEN", "text": "TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-17T23:35:39.403052", "hash": "b704ab89ed52a283729490c1cb2714ef"}, "stats": {"rule_based_entities": 8, "llm_entities": 0, "total_entities": 8, "rule_stats": {"REVIEW_TYPE": 2, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 4, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-17T23:35:39.403500", "hash": "e06836707d0ee7ee126060ed987d2bc8"}, "stats": {"rule_based_entities": 4, "llm_entities": 0, "total_entities": 4, "rule_stats": {"REVIEW_TYPE": 3, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 5, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 2, "DRUG_TYPE": 2, "DISEASE": 1, "EFFECT_MEASURE": 1}}}
{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\nMethods:\nWe searched PubMed, Scopus, and Web of Science from January 1990 to March 2024. \nAfter removing duplicates, 1,240 records were screened, and 137 full-text articles were assessed for eligibility.\nSeventy articles were excluded due to incomplete data, leaving 67 studies for analysis. \nTwo reviewers independently screened all titles and abstracts.\n\nResults:\nA total of 67 studies (n = 88,345 participants) from 25 countries were included. \nThe largest sample sizes were from China (n = 35,812), the United States (n = 10,437), and Germany (n = 7,670). \nOther notable sample sizes included Bangladesh (n = 2,909), Ethiopia (n = 2,033), Egypt (n = 3,204), and Vietnam (n = 2,945).\nFourteen were randomized controlled trials, ten cohort studies, and three case-control studies.\n", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 23, "end": 37, "label": "DRUG_TYPE", "text": "antiretroviral"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 102, "end": 105, "label": "PATHOGEN", "text": "HIV"}, {"start": 152, "end": 155, "label": "DRUG_TYPE", "text": "ART"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}, {"start": 498, "end": 508, "label": "N_STUDIES", "text": "67 studies"}, {"start": 608, "end": 618, "label": "N_STUDIES", "text": "67 studies"}, {"start": 620, "end": 630, "label": "SAMPLE_SIZE", "text": "n = 88,345"}, {"start": 714, "end": 719, "label": "COUNTRY", "text": "China"}, {"start": 721, "end": 731, "label": "SAMPLE_SIZE", "text": "n = 35,812"}, {"start": 738, "end": 751, "label": "COUNTRY", "text": "United States"}, {"start": 753, "end": 763, "label": "SAMPLE_SIZE", "text": "n = 10,437"}, {"start": 779, "end": 788, "label": "SAMPLE_SIZE", "text": "n = 7,670"}, {"start": 840, "end": 849, "label": "SAMPLE_SIZE", "text": "n = 2,909"}, {"start": 862, "end": 871, "label": "SAMPLE_SIZE", "text": "n = 2,033"}, {"start": 881, "end": 890, "label": "SAMPLE_SIZE", "text": "n = 3,204"}, {"start": 906, "end": 915, "label": "SAMPLE_SIZE", "text": "n = 2,945"}, {"start": 992, "end": 1004, "label": "STUDY_DESIGN", "text": "case-control"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 1014, "processing_time": "2025-12-17T23:37:16.973119", "hash": "15c82ac190e922a6da5864c93d3736d2"}, "stats": {"rule_based_entities": 19, "llm_entities": 0, "total_entities": 19, "rule_stats": {"REVIEW_TYPE": 1, "STUDY_DESIGN": 1, "N_STUDIES": 3, "PATHOGEN": 1, "COUNTRY": 2, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 21, "end": 23, "label": "PATHOGEN", "text": "TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-17T23:37:16.974437", "hash": "b704ab89ed52a283729490c1cb2714ef"}, "stats": {"rule_based_entities": 8, "llm_entities": 0, "total_entities": 8, "rule_stats": {"REVIEW_TYPE": 2, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 4, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-17T23:37:16.975284", "hash": "e06836707d0ee7ee126060ed987d2bc8"}, "stats": {"rule_based_entities": 4, "llm_entities": 0, "total_entities": 4, "rule_stats": {"REVIEW_TYPE": 3, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 5, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 2, "DRUG_TYPE": 2, "DISEASE": 1, "EFFECT_MEASURE": 1}}}
{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\nMethods:\nWe searched PubMed, Scopus, and Web of Science from January 1990 to March 2024. \nAfter removing duplicates, 1,240 records were screened, and 137 full-text articles were assessed for eligibility.\nSeventy articles were excluded due to incomplete data, leaving 67 studies for analysis. \nTwo reviewers independently screened all titles and abstracts.\n\nResults:\nA total of 67 studies (n = 88,345 participants) from 25 countries were included. \nThe largest sample sizes were from China (n = 35,812), the United States (n = 10,437), and Germany (n = 7,670). \nOther notable sample sizes included Bangladesh (n = 2,909), Ethiopia (n = 2,033), Egypt (n = 3,204), and Vietnam (n = 2,945).\nFourteen were randomized controlled trials, ten cohort studies, and three case-control studies.\n", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 23, "end": 37, "label": "DRUG_TYPE", "text": "antiretroviral"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 102, "end": 105, "label": "PATHOGEN", "text": "HIV"}, {"start": 152, "end": 155, "label": "DRUG_TYPE", "text": "ART"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}, {"start": 498, "end": 508, "label": "N_STUDIES", "text": "67 studies"}, {"start": 608, "end": 618, "label": "N_STUDIES", "text": "67 studies"}, {"start": 620, "end": 630, "label": "SAMPLE_SIZE", "text": "n = 88,345"}, {"start": 714, "end": 719, "label": "COUNTRY", "text": "China"}, {"start": 721, "end": 731, "label": "SAMPLE_SIZE", "text": "n = 35,812"}, {"start": 738, "end": 751, "label": "COUNTRY", "text": "United States"}, {"start": 753, "end": 763, "label": "SAMPLE_SIZE", "text": "n = 10,437"}, {"start": 779, "end": 788, "label": "SAMPLE_SIZE", "text": "n = 7,670"}, {"start": 840, "end": 849, "label": "SAMPLE_SIZE", "text": "n = 2,909"}, {"start": 862, "end": 871, "label": "SAMPLE_SIZE", "text": "n = 2,033"}, {"start": 881, "end": 890, "label": "SAMPLE_SIZE", "text": "n = 3,204"}, {"start": 906, "end": 915, "label": "SAMPLE_SIZE", "text": "n = 2,945"}, {"start": 992, "end": 1004, "label": "STUDY_DESIGN", "text": "case-control"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 1014, "processing_time": "2025-12-17T23:37:51.162961", "hash": "15c82ac190e922a6da5864c93d3736d2"}, "stats": {"rule_based_entities": 19, "llm_entities": 0, "total_entities": 19, "rule_stats": {"REVIEW_TYPE": 1, "STUDY_DESIGN": 1, "N_STUDIES": 3, "PATHOGEN": 1, "COUNTRY": 2, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 21, "end": 23, "label": "PATHOGEN", "text": "TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-17T23:37:51.164318", "hash": "b704ab89ed52a283729490c1cb2714ef"}, "stats": {"rule_based_entities": 8, "llm_entities": 0, "total_entities": 8, "rule_stats": {"REVIEW_TYPE": 2, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 4, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-17T23:37:51.165940", "hash": "e06836707d0ee7ee126060ed987d2bc8"}, "stats": {"rule_based_entities": 4, "llm_entities": 0, "total_entities": 4, "rule_stats": {"REVIEW_TYPE": 3, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 5, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 2, "DRUG_TYPE": 2, "DISEASE": 1, "EFFECT_MEASURE": 1}}}
{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\nMethods:\nWe searched PubMed, Scopus, and Web of Science from January 1990 to March 2024. \nAfter removing duplicates, 1,240 records were screened, and 137 full-text articles were assessed for eligibility.\nSeventy articles were excluded due to incomplete data, leaving 67 studies for analysis. \nTwo reviewers independently screened all titles and abstracts.\n\nResults:\nA total of 67 studies (n = 88,345 participants) from 25 countries were included. \nThe largest sample sizes were from China (n = 35,812), the United States (n = 10,437), and Germany (n = 7,670). \nOther notable sample sizes included Bangladesh (n = 2,909), Ethiopia (n = 2,033), Egypt (n = 3,204), and Vietnam (n = 2,945).\nFourteen were randomized controlled trials, ten cohort studies, and three case-control studies.\n", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 23, "end": 37, "label": "DRUG_TYPE", "text": "antiretroviral"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 102, "end": 105, "label": "PATHOGEN", "text": "HIV"}, {"start": 152, "end": 155, "label": "DRUG_TYPE", "text": "ART"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}, {"start": 498, "end": 508, "label": "N_STUDIES", "text": "67 studies"}, {"start": 608, "end": 618, "label": "N_STUDIES", "text": "67 studies"}, {"start": 620, "end": 630, "label": "SAMPLE_SIZE", "text": "n = 88,345"}, {"start": 714, "end": 719, "label": "COUNTRY", "text": "China"}, {"start": 721, "end": 731, "label": "SAMPLE_SIZE", "text": "n = 35,812"}, {"start": 738, "end": 751, "label": "COUNTRY", "text": "United States"}, {"start": 753, "end": 763, "label": "SAMPLE_SIZE", "text": "n = 10,437"}, {"start": 779, "end": 788, "label": "SAMPLE_SIZE", "text": "n = 7,670"}, {"start": 840, "end": 849, "label": "SAMPLE_SIZE", "text": "n = 2,909"}, {"start": 862, "end": 871, "label": "SAMPLE_SIZE", "text": "n = 2,033"}, {"start": 881, "end": 890, "label": "SAMPLE_SIZE", "text": "n = 3,204"}, {"start": 906, "end": 915, "label": "SAMPLE_SIZE", "text": "n = 2,945"}, {"start": 992, "end": 1004, "label": "STUDY_DESIGN", "text": "case-control"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 1014, "processing_time": "2025-12-17T23:38:41.853297", "hash": "15c82ac190e922a6da5864c93d3736d2"}, "stats": {"rule_based_entities": 19, "llm_entities": 0, "total_entities": 19, "rule_stats": {"REVIEW_TYPE": 1, "STUDY_DESIGN": 1, "N_STUDIES": 3, "PATHOGEN": 1, "COUNTRY": 2, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 21, "end": 23, "label": "PATHOGEN", "text": "TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-17T23:38:41.854239", "hash": "b704ab89ed52a283729490c1cb2714ef"}, "stats": {"rule_based_entities": 8, "llm_entities": 0, "total_entities": 8, "rule_stats": {"REVIEW_TYPE": 2, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 4, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-17T23:38:41.854677", "hash": "e06836707d0ee7ee126060ed987d2bc8"}, "stats": {"rule_based_entities": 4, "llm_entities": 0, "total_entities": 4, "rule_stats": {"REVIEW_TYPE": 3, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 5, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 2, "DRUG_TYPE": 2, "DISEASE": 1, "EFFECT_MEASURE": 1}}}
{"doc_id": "paper1", "text": "A systematic review of antiretroviral therapy adherence in Sub-Saharan Africa.\n42 studies with 15,000 HIV-positive patients were included.\nAdherence to ART was 78% (95% CI 72-84%).\nBarriers included stigma and distance to clinics.\nMethods:\nWe searched PubMed, Scopus, and Web of Science from January 1990 to March 2024. \nAfter removing duplicates, 1,240 records were screened, and 137 full-text articles were assessed for eligibility.\nSeventy articles were excluded due to incomplete data, leaving 67 studies for analysis. \nTwo reviewers independently screened all titles and abstracts.\n\nResults:\nA total of 67 studies (n = 88,345 participants) from 25 countries were included. \nThe largest sample sizes were from China (n = 35,812), the United States (n = 10,437), and Germany (n = 7,670). \nOther notable sample sizes included Bangladesh (n = 2,909), Ethiopia (n = 2,033), Egypt (n = 3,204), and Vietnam (n = 2,945).\nFourteen were randomized controlled trials, ten cohort studies, and three case-control studies.\n", "spans": [{"start": 2, "end": 19, "label": "REVIEW_TYPE", "text": "systematic review"}, {"start": 23, "end": 37, "label": "DRUG_TYPE", "text": "antiretroviral"}, {"start": 79, "end": 89, "label": "N_STUDIES", "text": "42 studies"}, {"start": 102, "end": 105, "label": "PATHOGEN", "text": "HIV"}, {"start": 152, "end": 155, "label": "DRUG_TYPE", "text": "ART"}, {"start": 165, "end": 171, "label": "CI", "text": "95% CI"}, {"start": 498, "end": 508, "label": "N_STUDIES", "text": "67 studies"}, {"start": 608, "end": 618, "label": "N_STUDIES", "text": "67 studies"}, {"start": 620, "end": 630, "label": "SAMPLE_SIZE", "text": "n = 88,345"}, {"start": 714, "end": 719, "label": "COUNTRY", "text": "China"}, {"start": 721, "end": 731, "label": "SAMPLE_SIZE", "text": "n = 35,812"}, {"start": 738, "end": 751, "label": "COUNTRY", "text": "United States"}, {"start": 753, "end": 763, "label": "SAMPLE_SIZE", "text": "n = 10,437"}, {"start": 779, "end": 788, "label": "SAMPLE_SIZE", "text": "n = 7,670"}, {"start": 840, "end": 849, "label": "SAMPLE_SIZE", "text": "n = 2,909"}, {"start": 862, "end": 871, "label": "SAMPLE_SIZE", "text": "n = 2,033"}, {"start": 881, "end": 890, "label": "SAMPLE_SIZE", "text": "n = 3,204"}, {"start": 906, "end": 915, "label": "SAMPLE_SIZE", "text": "n = 2,945"}, {"start": 992, "end": 1004, "label": "STUDY_DESIGN", "text": "case-control"}], "metadata": {"filepath": "infectious_disease_papers/paper1.txt", "file_size": 1014, "processing_time": "2025-12-17T23:40:43.418343", "hash": "15c82ac190e922a6da5864c93d3736d2"}, "stats": {"rule_based_entities": 19, "llm_entities": 0, "total_entities": 19, "rule_stats": {"REVIEW_TYPE": 1, "STUDY_DESIGN": 1, "N_STUDIES": 3, "PATHOGEN": 1, "COUNTRY": 2, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper2", "text": "Meta-analysis of MDR-TB treatment outcomes in high-burden countries.\n28 studies from India, China, and South Africa.\nTreatment success rate was 65% for MDR-TB vs 88% for drug-sensitive TB.", "spans": [{"start": 0, "end": 13, "label": "REVIEW_TYPE", "text": "Meta-analysis"}, {"start": 21, "end": 23, "label": "PATHOGEN", "text": "TB"}, {"start": 69, "end": 79, "label": "N_STUDIES", "text": "28 studies"}, {"start": 85, "end": 90, "label": "COUNTRY", "text": "India"}, {"start": 92, "end": 97, "label": "COUNTRY", "text": "China"}, {"start": 103, "end": 115, "label": "COUNTRY", "text": "South Africa"}, {"start": 156, "end": 158, "label": "PATHOGEN", "text": "TB"}, {"start": 185, "end": 187, "label": "PATHOGEN", "text": "TB"}], "metadata": {"filepath": "infectious_disease_papers/paper2.txt", "file_size": 188, "processing_time": "2025-12-17T23:40:43.419472", "hash": "b704ab89ed52a283729490c1cb2714ef"}, "stats": {"rule_based_entities": 8, "llm_entities": 0, "total_entities": 8, "rule_stats": {"REVIEW_TYPE": 2, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 4, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 1, "DRUG_TYPE": 2}}}
{"doc_id": "paper3", "text": "Systematic review of insecticide-treated bed net distribution.\nCoverage increased from 45% to 82% after community-based programs.\nMalaria incidence decreased by 67% (RR 0.33, 95% CI 0.25-0.44).", "spans": [{"start": 0, "end": 17, "label": "REVIEW_TYPE", "text": "Systematic review"}, {"start": 130, "end": 137, "label": "PATHOGEN", "text": "Malaria"}, {"start": 166, "end": 168, "label": "EFFECT_MEASURE", "text": "RR"}, {"start": 175, "end": 181, "label": "CI", "text": "95% CI"}], "metadata": {"filepath": "infectious_disease_papers/paper3.txt", "file_size": 193, "processing_time": "2025-12-17T23:40:43.420064", "hash": "e06836707d0ee7ee126060ed987d2bc8"}, "stats": {"rule_based_entities": 4, "llm_entities": 0, "total_entities": 4, "rule_stats": {"REVIEW_TYPE": 3, "STUDY_DESIGN": 1, "N_STUDIES": 4, "PATHOGEN": 5, "COUNTRY": 5, "SAMPLE_SIZE": 8, "CI": 2, "DRUG_TYPE": 2, "DISEASE": 1, "EFFECT_MEASURE": 1}}}
